NCT03894358

Brief Summary

The aim of this study is to measure the effect of a prebiotic (high dose/low dose) mixture at different doses within a wheat-based instant cereal, on fractional iron absorption (FIA), gut microbiota and inflammation after three weeks. FIA will be compared with and without three weeks of pre-feeding with two different doses of the prebiotic mixture.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
195

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Jul 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 7, 2019

Completed
21 days until next milestone

First Posted

Study publicly available on registry

March 28, 2019

Completed
4 months until next milestone

Study Start

First participant enrolled

July 23, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 4, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 4, 2020

Completed
Last Updated

May 12, 2020

Status Verified

May 1, 2020

Enrollment Period

6 months

First QC Date

March 7, 2019

Last Update Submit

May 11, 2020

Conditions

Outcome Measures

Primary Outcomes (2)

  • Fractional iron absorption (%)

    Fractional iron absorption (erythrocyte incorporation of stable iron isotopes after 14 days of meal) from the wheat-based instant cereal containing FeFum and AA, with and without a prebiotic mixture after single dosing

    Day 18

  • Fractional iron absorption (%)

    Fractional iron absorption (erythrocyte incorporation of stable iron isotopes after 14 days of meal) from the wheat-based instant cereal containing FeFum and AA, with and without a prebiotic mixture after long-term dosing

    Day 57

Secondary Outcomes (12)

  • Change in fecal Bifidobacteria abundance

    Day 18 and day 39

  • Plasma ferritin

    Baseline, Day 18, Day 39, Day 57

  • Soluble transferrin receptor

    Baseline, Day 18, Day 39, Day 57

  • C-reactive protein

    Baseline, Day 18, Day 39, Day 57

  • Alpha-1-acid glycoprotein

    Baseline, Day 18, Day 39, Day 57

  • +7 more secondary outcomes

Study Arms (3)

FeFum and 7.5 g prebiotic mixture

ACTIVE COMPARATOR

Intervention will be 3.6 mg Fe as Ferrous Fumarate and 7.5 g of prebiotic (high dose/low dose) mixture

Dietary Supplement: FeFum and 7.5 g prebiotic mixture

FeFum and 3 g prebiotic mixture

ACTIVE COMPARATOR

Intervention will be 3.6 mg Fe as Ferrous Fumarate and 3 g of prebiotic (high dose/low dose) mixture

Dietary Supplement: FeFum and 3 g prebiotic mixture

FeFum and no prebiotic mixture

ACTIVE COMPARATOR

Intervention will be 3.6 mg Fe as Ferrous Fumarate

Dietary Supplement: Fefum and no prebiotic mixture

Interventions

The 3 weeks intervention will consist of 24 g of wheat-based instant cereal and 90 ml of water per portion and will contain 3.6 mg FeFum and AA (molar ratio Fe:AA between 2.5 and 3) plus 7.5 g prebiotics mixture The absorption study test meals will consist of 24 g wheat-based instant cereal and 90 ml of water per portion and additionally: Test meal 1 will be composed of: 3.6 mg of Fe as 57FeFum and 0 g prebiotic mixture added extrinsically. Test meal 2 will be composed of: 3.6 mg of Fe as 1.5 mg iron as 58FeFum, 2.09 mg iron as 56FeFum and 7.5 g prebiotic mixture added extrinsically.

FeFum and 7.5 g prebiotic mixture

Standard wheat-based instant cereal containing 3.6 mg FeFum and AA (molar ratio Fe:AA between 2.5 and 3) plus 3 g prebiotics mixture per portion

FeFum and 3 g prebiotic mixture

Standard wheat-based instant cereal containing 3.6 mg FeFum and AA (molar ratio Fe:AA between 2.5 and 3) per portion.

FeFum and no prebiotic mixture

Eligibility Criteria

Age6 Months - 11 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • to 11 months at baseline
  • Anticipated residence in study area for the study duration
  • In good health as assessed by professional staff at Msambweni County Referral hospital
  • Caregiver is willing to participate and able to comply with study procedures
  • Informed consent form has been read and signed by the caregiver (or has been read out to the caregiver)

You may not qualify if:

  • Hemoglobin concentration less than 70 g/L
  • Severe underweight (Z-score weight-for-age \<-3)
  • Severe wasting (Z-score weight-for-height \<-3
  • Chronic or acute illness or other conditions that in the opinion of the Principal Investigator (PI) or study pediatrician would jeopardize the safety or rights of a participant in the trial or would render the participant unable to comply with the protocol
  • Participant taking part in other studies requiring the drawing of blood
  • Regular intake (\>2 days) of iron-containing mineral and vitamin supplements or fortified foods within the last 2 months
  • Antibiotic treatment in the past 4 weeks prior to study enrollment

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Msambweni County Referral Hospital

Msambweni, Kwale County, Kenya

Location

Related Publications (2)

  • Mikulic N, Uyoga MA, Stoffel NU, Derrien M, Nyilima S, Kostopoulos I, Roeselers G, Chenoll E, Mwasi E, Pironaci G, Karanja S, Bourdet-Sicard R, Zimmermann MB. Prebiotics increase iron absorption and reduce the adverse effects of iron on the gut microbiome and inflammation: a randomized controlled trial using iron stable isotopes in Kenyan infants. Am J Clin Nutr. 2024 Feb;119(2):456-469. doi: 10.1016/j.ajcnut.2023.11.018. Epub 2023 Nov 30.

  • Derrien M, Mikulic N, Uyoga MA, Chenoll E, Climent E, Howard-Varona A, Nyilima S, Stoffel NU, Karanja S, Kottler R, Stahl B, Zimmermann MB, Bourdet-Sicard R. Gut microbiome function and composition in infants from rural Kenya and association with human milk oligosaccharides. Gut Microbes. 2023 Jan-Dec;15(1):2178793. doi: 10.1080/19490976.2023.2178793.

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal investigator

Study Record Dates

First Submitted

March 7, 2019

First Posted

March 28, 2019

Study Start

July 23, 2019

Primary Completion

January 4, 2020

Study Completion

January 4, 2020

Last Updated

May 12, 2020

Record last verified: 2020-05

Data Sharing

IPD Sharing
Will not share

Locations